Arrowhead Wins NICE Recommendation for NHS Funding of REDEMPLO

Arrowhead said NICE recommended NHS funding for REDEMPLO (plozasiran) for adults with genetically confirmed familial chylomicronemia syndrome in England and Wales, following UK marketing authorisation.